Johnson & Johnson Services, Inc., AbbVie Inc. and Sientra, Inc. are Dominating in the North America Breast Reconstruction Market in 2019

North America Breast Reconstruction Market is expected to grow with the CAGR of 8.2% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-breast-reconstruction-market

North America breast reconstruction market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in North America breast reconstruction market are introducing strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition, agreement into the breast reconstruction market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in April 2017, RTI Surgical launched its new product named as Fortiva Tissue Matrix line derived from porcine dermis targeted specially for the breast reconstruction market. This new product launched by the company has strengthened its plastic and reconstructive surgery product portfolio in the market.

Johnson & Johnson Services, Inc. is the dominating player in North America breast reconstruction market. The other key players existing in the breast reconstruction market includes AbbVie Inc., Sientra, Inc., IDEAL IMPLANT INCORPORATED, Establishment Labs S.A., CEREPLAS, DPS Technology Development Ltd, LABORATOIRES ARION, Integra LifeSciences, RTI Surgical, PMT Corporation, AirXpanders, Inc. and DEFYGRAVITY among others.

Johnson & Johnson Services, Inc.:

Johnson & Johnson Services, Inc. is headquartered in New Jersey, U.S. and was incorporated in 1887. The company is engaged in the research and development, manufacturing and sale of the broad range of products in the health care field. The company deals in various business segments such as consumer, pharmaceutical and medical devices among which medical devices is the market focused segment. The company is providing products under categories such as consumer health products, medical devices and pharmaceutical products out of which medical devices is the market focused category. The company is taking various strategic initiatives in order to expand its business in the market.

For instance,

  • In March 2019, Johnson & Johnson Services, Inc.’s brand Mentor received Food and Drug Administration (FDA) approval for the MemoryShape device under Premarket Approval (PMA) application. This has helped the company in expanding their portfolio in the breast reconstruction market.

The company has wide presence across Asia-Pacific, Europe, Middle East and Africa, North America and South America. The company has various subsidiaries such as Acclarent, Inc. (U.S.), Ethicon Endo-Surgery, Inc. (U.S.), Actelion Pharmaceuticals Japan Ltd. (Japan), AMO Belgium BVBA (Belgium) and AMO Germany GmbH (Germany) among more.

AbbVie Inc.

AbbVie Inc. is headquartered in Illinois, U.S. and was founded in 2013. The company is a research-driven biopharmaceutical company which is engaged in providing therapeutics for the areas including immunology, oncology and neuroscience among more. The company has multiple business segments such as US specialized therapeutics, US general medicine, international and other in which US specialized therapeutics is the market focused segment. The company is providing products under categories such as central nervous system, eye care, gastroenterology, medical aesthetics and other among which medical aesthetics is the market focused category. The company is engaged in expanding its business via various strategic initiatives.

For instance,

  • In July 2017, AbbVie Inc. announced that its subsidiary Allergan Sales LLC acquired Keller Medical, which is creator of the Keller Funnel used in breast augmentation and reconstruction procedures. The Keller Funnel is a shape of cone which reduces surgeon and patient contact during the procedures. This silicone gel implants allows the surgeons to use “no touch technique”, this technique minimizes the bacteria and foreign material in the surgical area. This acquisition has strengthened the medical aesthetics business of the company.

The company has wide presence across Europe, North America, South America, Asia-Pacific and Middle East and Africa. The company also has various subsidiary companies such as AbbVie Holdings Inc. (U.S.), AbbVie Pty Ltd (Australia), AbbVie SA (Belgium), AbbVie Farmacêutica Ltda. (Brazil) and AbbVie Productos Farmacéuticos Limitada (Chile) among others.

Sientra, Inc.:

Sientra, Inc. is headquartered in California, U.S. and was founded in 2003. The company is engaged in the development and distribution of aesthetic medical products such as breast implants, tissues expanders among other. The company has multiple business segments such as breast products and miradry in which breast products is the market focused segment. The company is engaged in providing products under categories such as breast augmentation, breast reconstruction, advanced scar treatment and miraDry among which breast augmentation and breast reconstruction are the market focused categories. The company has initiated many strategic initiatives to expand its market.

For instance,

  • In July2019, Sientra, Inc. acquired the manufacturing operations of the FDA-approved silicone breast implant n Franklin, Wisconsin from Lubrizol Life Science. This acquisition done by the company has strengthened its breast products business in the market leading to increased sales in future.

The company has wide presence across Europe, North America, South America, Middle East and Africa, Asia-Pacific. The company has various subsidiary companies such as miraDry Holdings, Inc. (U.S.), miraDry, Inc. (U.S.), miraDry International, Inc. (U.S.), Miramar Labs HK Ltd (China) and miraDry International Sweden AB (Sweden) among more.